View in EDS HTML Full Text PDF Full Text

Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma.

Saved in:
Bibliographic Details
Title: Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma.
Authors: Hanssen, Kimberley M.1,2 (AUTHOR), Murray, Jayne1,2 (AUTHOR), Pandher, Ruby1,2 (AUTHOR), Alfred, Stephanie1 (AUTHOR), Gamble, Laura D.1 (AUTHOR), Brand, Jennifer1 (AUTHOR), Mosmann, Erin1 (AUTHOR), Kusuma, Frances K.1 (AUTHOR), Mak, Crystal1 (AUTHOR), Kearns, Adam1 (AUTHOR), Kamili, Alvin1,2 (AUTHOR), Atkinson, Caroline1,2 (AUTHOR), Minchaca, Alexis Z.1,2 (AUTHOR), Bertoldo, Jean1,2 (AUTHOR), Ziegler, David S.1,2,3 (AUTHOR), Mussai, Francis4 (AUTHOR), Cheng, Paul N. M.5 (AUTHOR), Norris, Murray D.1,6 (AUTHOR), Fletcher, Jamie I.1,2 (AUTHOR) jfletcher@ccia.org.au, Haber, Michelle1,2 (AUTHOR) mhaber@ccia.org.au
Source: Journal of Experimental & Clinical Cancer Research (17569966). 8/14/2025, Vol. 44 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17569966
DOI:10.1186/s13046-025-03502-8